Skip to main content
Top
Published in: CEN Case Reports 1/2015

01-05-2015 | Case Report

A case of membranoproliferative glomerulonephritis and AA amyloidosis complicated with pulmonary nontuberculous mycobacterial infection

Authors: Kiyokazu Tsuji, Hideyuki Arai, Akira Furusu, Kenta Torigoe, Ayuko Tokuyama, Yoshiaki Muraya, Masahiro Nakashima, Takashi Taguchi, Yoko Obata, Tomoya Nishino, Shigeru Kohno

Published in: CEN Case Reports | Issue 1/2015

Login to get access

Abstract

A 75-year-old man was diagnosed with pulmonary nontuberculous mycobacterial (NTM) infection in February 2005 and was treated with rifampicin, ethambutol, and clarithromycin. However, the infection was resistant to treatment, and his chest radiograph showed an abnormality that gradually seemed to aggravate. The patient’s sputum was positive for Mycobacteria. Moreover, the patient had dyspnea and an underlying chronic inflammation in the lungs. He visited our hospital because of dyspnea and leg edema in June 2011. Laboratory evaluation on admission revealed proteinuria (6 g/day) and decreased serum total protein (5.8 g/dL) and albumin (1.6 g/dL) levels, indicating nephrotic syndrome. Percutaneous renal biopsy revealed membranoproliferative glomerulonephritis (MPGN) in the acute stage and AA amyloidosis of mild degree. AA amyloidosis was also diagnosed histologically on gastric and colonic biopsy, in addition to renal biopsy. His renal function decreased gradually, and therefore, he underwent hemodialysis therapy in January 2012. However, his gastrointestinal-related symptoms persisted, and his appetite diminished, because of which he had become severely malnourished; he died 8 months later. This is a rare case of a patient with two different renal lesions (MPGN and AA amyloidosis) complicated with NTM. Our case suggests that MPGN and amyloidosis should be considered in elderly patients with nephrotic syndrome onset and chronic inflammation.
Literature
1.
go back to reference Morimoto K, Iwai K, Ohmori M, et al. Nontuberculous mycobacteriosis mortality in Japan. Kekkaku. 2011;86:547–52.PubMed Morimoto K, Iwai K, Ohmori M, et al. Nontuberculous mycobacteriosis mortality in Japan. Kekkaku. 2011;86:547–52.PubMed
2.
go back to reference The Nontuberculous Mycobacteriosis Control Committee of the Japanese Society for Tuberculosis. Scientific Assembly for Infection and Tuberculosis of the Japanese Respiratory Society. Guidelines for chemotherapy of pulmonary nontuberculous mycobacterial disease—2012 revised version. Kekkaku. 2013;88:29–32. The Nontuberculous Mycobacteriosis Control Committee of the Japanese Society for Tuberculosis. Scientific Assembly for Infection and Tuberculosis of the Japanese Respiratory Society. Guidelines for chemotherapy of pulmonary nontuberculous mycobacterial disease—2012 revised version. Kekkaku. 2013;88:29–32.
3.
go back to reference Osoreda H, Kobayashi H. Chronological change of primary type pulmonary Mycobacterium avium-intracellulare complex infection. Kekkaku. 2010;85:447–52.PubMed Osoreda H, Kobayashi H. Chronological change of primary type pulmonary Mycobacterium avium-intracellulare complex infection. Kekkaku. 2010;85:447–52.PubMed
4.
go back to reference Yokoyama H, Sugiyama H, Sato H, et al. Committee for the Standardization of Renal Pathological Diagnosis and for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology, and the Progressive Renal Disease Research of the Ministry of Health, Labour and Welfare of Japan. Clin Exp Nephrol. 2012;16:903–20.CrossRefPubMed Yokoyama H, Sugiyama H, Sato H, et al. Committee for the Standardization of Renal Pathological Diagnosis and for Renal Biopsy and Disease Registry of the Japanese Society of Nephrology, and the Progressive Renal Disease Research of the Ministry of Health, Labour and Welfare of Japan. Clin Exp Nephrol. 2012;16:903–20.CrossRefPubMed
5.
go back to reference Bomback AS, Appel GB. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol. 2012;8:634–42.CrossRefPubMed Bomback AS, Appel GB. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol. 2012;8:634–42.CrossRefPubMed
6.
7.
go back to reference West CD. Childhood membranoproliferative glomerulonephritis: an approach to management. Kidney Int. 1986;29:1077–93.CrossRefPubMed West CD. Childhood membranoproliferative glomerulonephritis: an approach to management. Kidney Int. 1986;29:1077–93.CrossRefPubMed
8.
go back to reference Cameron JS, Turner DR, Heaton J, Williams DG, et al. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med. 1983;74:175–92.CrossRefPubMed Cameron JS, Turner DR, Heaton J, Williams DG, et al. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. Am J Med. 1983;74:175–92.CrossRefPubMed
9.
10.
go back to reference Matsuo S, Imai E, et al. Guidelines for the treatment of nephrotic syndrome. Nihon Jinzo Gakkai Shi. 2011;53:78–122. Matsuo S, Imai E, et al. Guidelines for the treatment of nephrotic syndrome. Nihon Jinzo Gakkai Shi. 2011;53:78–122.
11.
go back to reference Pecchini F, Bufano G, Ghiringhelli P. Membranoproliferative glomerulonephritis secondary to tuberculosis. Clin Nephrol. 1997;47:63–4.PubMed Pecchini F, Bufano G, Ghiringhelli P. Membranoproliferative glomerulonephritis secondary to tuberculosis. Clin Nephrol. 1997;47:63–4.PubMed
12.
go back to reference Meyrier A, Valensi P, Sebaoun J. Mesangio-capillary glomerulonephritis and the nephrotic syndrome in the course of disseminated tuberculosis. Nephron. 1988;49:341–2.CrossRefPubMed Meyrier A, Valensi P, Sebaoun J. Mesangio-capillary glomerulonephritis and the nephrotic syndrome in the course of disseminated tuberculosis. Nephron. 1988;49:341–2.CrossRefPubMed
13.
go back to reference Toyoshima H, Kusaba T, Yamaguchi M. Cause of death in autopsied RA patients. Ryumachi. 1993;33:209–14.PubMed Toyoshima H, Kusaba T, Yamaguchi M. Cause of death in autopsied RA patients. Ryumachi. 1993;33:209–14.PubMed
14.
go back to reference Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore). 1991;70:246–56.CrossRef Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore). 1991;70:246–56.CrossRef
15.
go back to reference Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361–71.CrossRefPubMed Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361–71.CrossRefPubMed
16.
go back to reference Zaizen Yukihiro, Arita Kazuhiro, Kawano Hiroshi, et al. Case report of AA amyloidosis associated with cystic infection during the course of non-tuberculous mycobacteriosis. Kokyu Junkan. 2007;55:237–41. Zaizen Yukihiro, Arita Kazuhiro, Kawano Hiroshi, et al. Case report of AA amyloidosis associated with cystic infection during the course of non-tuberculous mycobacteriosis. Kokyu Junkan. 2007;55:237–41.
17.
go back to reference Shinozuka N, Kasamatsu N, Seto T, et al. A fatal case of pulmonary non-tuberculous mycobacteriosis with reactive AA amyloidosis. Nihon Kokyuki Gakkai Zasshi. 2007;45:636–42.PubMed Shinozuka N, Kasamatsu N, Seto T, et al. A fatal case of pulmonary non-tuberculous mycobacteriosis with reactive AA amyloidosis. Nihon Kokyuki Gakkai Zasshi. 2007;45:636–42.PubMed
18.
go back to reference Haga Takahiro, Kasamatsu Norio, Kobayashi Takeshi, et al. A case of pulmonary nontuberculous mycobacteriosis with reactive AA amyloidosis exacerbated in spite of various antimicrobial therapy. Jpn J Chest Dis. 2009;68:245–51. Haga Takahiro, Kasamatsu Norio, Kobayashi Takeshi, et al. A case of pulmonary nontuberculous mycobacteriosis with reactive AA amyloidosis exacerbated in spite of various antimicrobial therapy. Jpn J Chest Dis. 2009;68:245–51.
Metadata
Title
A case of membranoproliferative glomerulonephritis and AA amyloidosis complicated with pulmonary nontuberculous mycobacterial infection
Authors
Kiyokazu Tsuji
Hideyuki Arai
Akira Furusu
Kenta Torigoe
Ayuko Tokuyama
Yoshiaki Muraya
Masahiro Nakashima
Takashi Taguchi
Yoko Obata
Tomoya Nishino
Shigeru Kohno
Publication date
01-05-2015
Publisher
Springer Japan
Published in
CEN Case Reports / Issue 1/2015
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-014-0134-1

Other articles of this Issue 1/2015

CEN Case Reports 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.